Avantor (AVTR)
(Delayed Data from NYSE)
$22.37 USD
+1.20 (5.67%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $22.36 -0.01 (-0.04%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Avantor, Inc. [AVTR]
Reports for Purchase
Showing records 81 - 100 ( 134 total )
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Post 1Q Beat & Raise and Likely to Exceed Estimates in FY21
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
More of the "New" Avantor with Ritter Acquisition
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Bioproduction: Sartorius Guide - Powerful COVID-19 Acceleration
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Life Science Tools: Hard and Soft Landings for COVID-19 Diagnostics and Vaccines
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Bioproduction: Three "Nuggets" from Earnings Season - Growth, Inflection Point & Decline
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Bioproduction Seems to Present Upside to 2021 Guidance
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Bioproduction: ''Guten Morgan Europe'' - Positive 2021 Industry Guides from Lonza and Sartorius
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
A Fundamentally Better Story Still Underappreciated; Raising PT to $40
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Life Science Tools: DC Never Friendlier with Biden "American Rescue Plan"
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
D.C. Very Friendly with Biden "American Rescue Plan";
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
4Q Pre-Announcement Indicates Set Up & Visibility Into FY21
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Modeling COVID-19: Vaccine and Diagnostic Demand Outlook with Herd Immunity in 2021
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department